Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissection of the catalytic and regulatory structure-function relationships of Csk protein tyrosine kinase. | Front Cell Dev Biol | 2023 | 36936693 | PubTator, text mining | PubMed |
| Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas. | Nat Mater | 2023 | 36928381 | PubTator, text mining | PubMed |
| Controlling Ibrutinib's Conformations about Its Heterobiaryl Axis to Increase BTK Selectivity. | ACS Med Chem Lett | 2023 | 36923918 | PubTator, text mining | PubMed |
| Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies. | Nat Rev Rheumatol | 2023 | 36914790 | PubTator, text mining | PubMed |
| Host Blood Transcriptional Signatures as Candidate Biomarkers for Predicting Progression to Active Tuberculosis. | Tuberc Respir Dis (Seoul) | 2023 | 36912017 | PubTator, text mining | PubMed |
| WiTransformer: A Novel Robust Gesture Recognition Sensing Model with WiFi. | Sensors (Basel) | 2023 | 36904814 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials. | Molecules | 2023 | 36903645 | PubTator, text mining | PubMed |
| The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 36902280 | PubTator, text mining | PubMed |
| Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton's tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics. | PLoS One | 2023 | 36897912 | PubTator, text mining | PubMed |
| Luxeptinib interferes with LYN-mediated activation of SYK and modulates BCR signaling in lymphoma. | PLoS One | 2023 | 36888611 | PubTator, text mining | PubMed |
| PrismEXP: gene annotation prediction from stratified gene-gene co-expression matrices. | PeerJ | 2023 | 36874981 | PubTator, text mining | PubMed |
| Novel gene mutation in maturity-onset diabetes of the young: A case report. | World J Clin Cases | 2023 | 36874436 | PubTator, text mining | PubMed |
| TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN. | Signal Transduct Target Ther | 2023 | 36854750 | PubTator, text mining | PubMed |
| Tyrosine kinases in nodal peripheral T-cell lymphomas. | Front Oncol | 2023 | 36845713 | PubTator, text mining | PubMed |
| Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures. | Pharmaceutics | 2023 | 36839692 | PubTator, text mining | PubMed |
| The Mutation Spectrum of Rare Variants in the Gene of Adenosine Triphosphate (ATP)-Binding Cassette Subfamily C Member 8 in Patients with a MODY Phenotype in Western Siberia. | J Pers Med | 2023 | 36836406 | PubTator, text mining | PubMed |
| Novel Bruton's tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis. | PLoS One | 2023 | 36821545 | PubTator, text mining | PubMed |
| Pathogenesis and treatment of Sjogren's syndrome: Review and update. | Front Immunol | 2023 | 36817420 | PubTator, text mining | PubMed |
| Strategy toward Kinase-Selective Drug Discovery. | J Chem Theory Comput | 2023 | 36815703 | PubTator, text mining | PubMed |
| PIWIL2 Regulates the Proliferation, Apoptosis and Colony Formation of Colorectal Cancer Cell Line. | Iran J Biotechnol | 2023 | 36811102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=14